Source: Eur Respir J 2012; 39: 795-796
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mantovani A.. Pentraxin-3 in COPD: innocent bystander or amplifier?. Eur Respir J 2012; 39: 795-796

Member's Comments

No comment yet.

Related content which might interest you: Passive smoking, the workplace and COPD: an innocent bystander effect? Source: Annual Congress 2010 - Novel risk factors and the global burden of nonsmoking COPD Year: 2010 Adaptive immune system in COPD: auto-immunity or bystander? Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD" Year: 2012 COPD: Still a Cinderella? Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003 The chronic cough – a suspect innocent or a guilty by-stander Source: Eur Respir J 2006; 28: Suppl. 50, 234s Year: 2006 Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - PRO Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 What is COPD? What is asthma? Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Interleukin-6 as a biomarker for asthma: hype or is there something else? Source: Eur Respir J 2016; 48: 979-981 Year: 2016 The immune system in COPD: guilty as charged? Source: International Congress 2016 – Immunity in COPD Year: 2016 Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis? Source: Eur Respir J 2015; 46: 303-306 Year: 2015 Presentation by an expert: The misunderstood neutrophil in COPD Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - CON Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Targeting neutrophils in asthma: a strategy shared with COPD? Source: Annual Congress 2012 - Are neutrophils a suitable target in severe asthma? Year: 2012 Club cells and CC16: another “smoking gun”? (With potential bullets against COPD) Source: Eur Respir J 2015; 45: 1519-1520 Year: 2015 T-cells in COPD: harmful or protective? Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD" Year: 2012 COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Eosinophils in COPD: do they predict drug response? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 Wheeze and crackles: how much does the workplace contribute? Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working? Year: 2020 Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction? Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013